PCM
KURA icon

Penserra Capital Management’s Kura Oncology KURA Stock Holding History

Penserra Capital Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,515
Closed -$28K – 1462
2021
Q3 		$28K Buy
1,515
+5
+0.3% +$94 ﹤0.01% 1196
2021
Q2 		$31K Buy
1,510
+15
+1% +$372 ﹤0.01% 1089
2021
Q1 		$42K Buy
1,495
+195
+15% +$6.17K ﹤0.01% 840
2020
Q4 		$42K Buy
1,300
+820
+171% +$28.8K ﹤0.01% 715
2020
Q3 		$14K Buy
+480
New +$10.6K ﹤0.01% 779

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Penserra Capital Management's KURA Position: Q4 2021 in Review

Penserra Capital Management sold out of Kura Oncology (KURA) in Q4 2021, closing a stake of 1,515 shares — an estimated $28K sold.

Penserra Capital Management first reported a position in KURA in Q3 2020 and held it in 5 quarters. The position peaked at $42K in Q1 2021. 151 funds tracked by Wall St. Rank hold KURA as of Q4 2021.

  • Penserra Capital Management reported no remaining Kura Oncology position as of Q4 2021 after selling out during the quarter.
  • Penserra Capital Management sold 1,515 Kura Oncology shares in Q4 2021, an estimated $28K.
  • Penserra Capital Management first reported a position in Kura Oncology in Q3 2020 and held it in 5 quarters.
  • Penserra Capital Management's Kura Oncology position peaked at $42K in Q1 2021.
  • 151 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.